# Safety Trial Of CTX Cells In Patients With Lower Limb Ischaemia

> **NCT01916369** · PHASE1 · COMPLETED · sponsor: **ReNeuron Limited** · enrollment: 5 (actual)

## Conditions studied

- Peripheral Arterial Disease

## Interventions

- **BIOLOGICAL:** CTX DP

## Key facts

- **NCT ID:** NCT01916369
- **Lead sponsor:** ReNeuron Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2018-01-16
- **Final completion:** 2018-01-16
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2018-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01916369

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01916369, "Safety Trial Of CTX Cells In Patients With Lower Limb Ischaemia". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01916369. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*